Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

5-Aminouracil

    • Product Name 5-Aminouracil
    • Alias 2,4-Dihydroxy-5-aminopyrimidine
    • Einecs 207-085-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    626550

    chemical_name 5-Aminouracil
    cas_number 1762-34-1
    molecular_formula C4H4N4O2
    molecular_weight 140.10 g/mol
    appearance White to off-white powder
    melting_point 300 °C (dec.)
    solubility_in_water Slightly soluble
    pubchem_cid 9203
    iupac_name 5-Amino-2,4(1H,3H)-pyrimidinedione

    As an accredited 5-Aminouracil factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 5-Aminouracil, 25g: Supplied in a sealed, amber glass bottle with tamper-evident cap, labeled with chemical details and safety information.
    Shipping 5-Aminouracil should be shipped in tightly sealed containers, protected from moisture and light. The packaging must comply with all regulatory and safety guidelines, including correct labeling. During transit, ensure the material is handled with care to prevent spills or contamination, and store at controlled room temperature unless otherwise specified.
    Storage 5-Aminouracil should be stored in a tightly closed container, protected from light and moisture, at a cool temperature (2-8°C or room temperature if specified by the manufacturer). Ensure the storage area is well-ventilated and free from incompatible substances, such as strong oxidizers. Handle and store following appropriate laboratory safety protocols to avoid contamination and degradation.
    Application of 5-Aminouracil

    Applications of 5-Aminouracil in Industrial Manufacturing

    5-Aminouracil serves as a critical intermediate in several specialized sectors that demand high purity and strict compliance with industry standards. Our direct manufacturing capabilities ensure full traceability and consistent specification control for downstream partners. The following application scenarios represent the primary industries utilizing this material, each with distinct requirements and process approaches.

    1. Pharmaceutical Synthesis of Antiviral Nucleoside Drugs

    Pharmaceutical manufacturers incorporate 5-Aminouracil in the synthesis pathway of select nucleoside analogs, leveraging its specific amine group for targeted modifications at the pyrimidine ring. The compound undergoes further derivatization and glycosylation, forming essential building blocks in the production of antiviral treatments. Downstream protocols require tight reaction parameter controls, particularly in multistep nucleoside coupling, to meet strict pharmacopeia benchmarks. Quality assurance focuses on trace impurities and batch-to-batch reproducibility to support regulatory submissions in finished drug formulations.

    Industry compliance standards

    • United States Pharmacopeia (USP) for APIs
    • European Pharmacopoeia (Ph. Eur.)
    • ICH Q7 Good Manufacturing Practices for Active Pharmaceutical Ingredients
    • FDA and EMA guidelines for drug substance traceability

    Typical usage ratio

    • 0.4%–1.1% as a molar fraction relative to the key substrate in nucleoside analog synthesis; the exact percentage adjusts according to the target compound structure and process scale-up requirements

    Downstream process integration

    • Primary role in the early to mid-stage heterocyclic amination and glycosylation reactions; clean-room compliant reactors and cGMP-compliant purification steps integrate immediately after charging the raw material

    Final product types

    • Finished antiviral drug substances such as brivudine, idoxuridine, and analogous nucleoside antivirals
    • Ready-for-formulation active pharmaceutical ingredient (API) powders

    2. Manufacture of Pyrimidine-Modified DNA Probes for Molecular Diagnostics

    Specialty oligonucleotide producers utilize 5-Aminouracil as a reactive precursor for the synthesis of modified bases in DNA probes and primers used in genetic analysis platforms. The unique aminated structure supports site-specific labeling and enhanced hybridization properties, particularly in qPCR and SNP detection workflows. Strict documentation of lot uniformity and residual solvent levels is mandatory to eliminate false positives or assay interference in diagnostic readouts.

    Industry compliance standards

    • ISO 13485:2016 for medical device quality management
    • OECD Principles of Good Laboratory Practice (GLP)
    • FDA 21 CFR Part 820 for in vitro diagnostic manufacturers
    • Analytical purity per custom oligo synthesis protocols

    Typical usage ratio

    • 0.2–0.5 mmol per synthesis batch, constituting up to 0.7% of the total base composition, depending on the degree of modification required in final probe design

    Downstream process integration

    • Direct coupling into automated DNA/RNA synthesizers following standard deprotection cycles; post-synthesis purification includes HPLC and desalting to remove unreacted intermediates and byproducts

    Final product types

    • Pyrimidine-modified oligonucleotides
    • Fluorescently-labeled DNA probes and primers for PCR, qPCR, and microarray applications

    3. Production of Antineoplastic Pyrimidine Derivatives

    Chemical bulk plants engaged in oncology pharmaceutical intermediate supply chains rely on 5-Aminouracil to construct specialized pyrimidine rings for subsequent alkylation, halogenation, or side-chain modification. The material plays a key role in defining side group orientation and electronic properties crucial for cytostatic activity. Production lines must monitor intermediate purity above 99% and strictly document solvent and residual metal contents to satisfy downstream pharmacological assessment and certification.

    Industry compliance standards

    • Ph. Eur. and USP for intermediate grade substances
    • EU EudraLex Volume 4: GMP for APIs
    • ICH Q3D for elemental impurity control in APIs
    • REACH registration for manufacturing and use within the EU

    Typical usage ratio

    • Usually 1.2–2.0 molar equivalents relative to the initial acylating agent, depending on precise synthetic pathway and purification efficiency

    Downstream process integration

    • Enters as the initial pyrimidine core at the beginning of multi-step batch synthesis, with staged derivatization and isolation of protected intermediates for downstream coupling

    Final product types

    • Antineoplastic intermediates for drugs such as fluoropyrimidine derivatives
    • Clinical candidate compounds for oral and injectable cancer treatments

    4. Development of Veterinary Pharmaceutical Intermediates

    Veterinary medicine producers source 5-Aminouracil to synthesize intermediates for animal antiviral and anticoccidial agents. Safety standards in this field require vigilance regarding cross-contamination and consistent removal of low-level byproducts that could transfer to feed applications. Material handling and storage protocols are designed to maintain batch integrity throughout semi-automated and continuous flow synthesis operations common in veterinary supply chains.

    Industry compliance standards

    • VICH GLs (Veterinary International Cooperation on Harmonization of Technical Requirements)
    • GMP compliance for veterinary substance manufacturing
    • National veterinary pharmacopoeias (e.g., Chinese Veterinary Pharmacopoeia, European Pharmacopoeia)
    • OIE guidelines for veterinary drug ingredients

    Typical usage ratio

    • 0.6–1.3% by mass of the primary ingredient load, customized according to species-specific dosage targeting and end-use pharmacokinetic analysis

    Downstream process integration

    • Charged directly into batch reactors during the first chemical transformation stage, followed by filtration, solvent-extraction, and recrystallization under monitored veterinary GMP environments

    Final product types

    • Veterinary antiviral and coccidiostat intermediates
    • Precursor APIs for oral, injectable, and feed additive formulations for livestock
    Free Quote

    Competitive 5-Aminouracil prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 5-Aminouracil: A Manufacturer’s Perspective

    Understanding 5-Aminouracil from the Source

    We’ve spent years working hands-on with 5-Aminouracil in our facility. The way this molecule has come to play a meaningful role in pharmaceuticals and biochemical research comes down to practical qualities, not just what you find on a datasheet. Every batch reflects our experience with complex synthesis, insights built up by dealing with the substance daily.

    5-Aminouracil stands out as a pyrimidine analog, meaning its structure closely relates to natural nucleic acid components. This similarity allows it to fit where uracil or cytosine might, but its amino group at the 5-position changes how it interacts in chemical reactions and biological systems. Because we control production from raw materials onward, we invest extensive attention in the purity and physical properties. Researchers detect even small impurities, so strict process controls support their requirements.

    Chemically, 5-Aminouracil appears as a white to slightly off-white powder, free from the strong odor you might expect with some nitrogenous compounds. Its molecular formula, C4H5N3O2, defines a straightforward molecule but achieving a consistently high-quality product takes more than understanding a structure on paper. We pay close attention to factors such as crystal habit, moisture absorption, and particle size, since each batch can behave a bit differently under laboratory or industrial conditions.

    Production Matters: How We Approach Quality

    During production, we avoid shortcuts. Solvent selection, temperature profiles, and pH control all impact the attributes seen by scientists and formulators. Our teams use analytical methods like NMR, HPLC, and IR to confirm structure and purity, and we check for residual solvents and inorganic contaminants. A production run only moves forward after thoroughly clearing these hurdles.

    A key challenge in 5-Aminouracil synthesis involves managing side reactions. Leaving too many impurities behind not only diminishes the yield, but can also interfere with downstream applications. Our processes limit such issues by careful reagent selection and equipment maintenance. Each crew member tracks small variances—signals like a color shift during precipitation or even a minor change in filtration rate often lead us to tweak protocols before a problem scales up.

    Model, Specifications, and Consistency

    With 5-Aminouracil, we supply several grades, usually differentiated by purity and trace element profiles. Researchers working on PCR or molecular biology need extremely low levels of metal ions and organic residues. For those using it as a synthetic intermediate, tight control over melting point and water content stays just as important. The exact specifications shift based on end use, but we assemble plenty of test data to support scientists and formulators in their work.

    Specifications for our material typically include:

    In every batch, these criteria keep things reliable for the technicians in the next laboratory. We do not chase the broadest market—crews here pay close attention to the users who need reproducible results, and we pursue feedback from their early projects to improve our processes. These subtle changes matter more than wholesale marketing claims, especially for advanced research and QC in regulated environments.

    Applications: Real-World Uses and Experiences

    In our experience, most 5-Aminouracil shipments go to pharmaceutical and research organizations. The compound features heavily in genetic studies, as a base analog for the investigation of DNA and RNA structure. Because it installs a primary amine group at the five-position, 5-Aminouracil alters base-pairing properties and challenges polymerase fidelity—this trait makes it functional in mutation detection or artificial nucleotide experiments.

    Therapeutic R&D teams have also explored derivatives for antitumor and antiviral applications. Some clients deploy our product as a building block in chemical syntheses where they modify the uracil core, using nucleophilic displacement or N-alkylation reactions that demand clean input material. We collaborate closely with those following up on patents and new drug candidates, since process robustness in the pilot lab translates directly to regulatory compliance.

    We’ve heard from some academic groups working on enzyme assays who value stability above all. They report that off-colour batches or dust contamination can interfere with their kinetic studies. To meet those needs, we focus extra effort on post-synthesis purification steps and keep cycle times rapid to minimize storage-related degradation. In return, we see greater success in downstream molecular labeling or modification steps.

    Practical Differences from Uracil and Other Analogs

    5-Aminouracil shares similarities with uracil and other pyrimidines, but the amino substitution delivers clear advantages for target applications. Consider an ordinary batch of uracil—odds are, chemists use it in neutral pH environments with standard nucleic acid protocols. Swap in 5-Aminouracil, and that amino group brings new possibilities. It shifts hydrogen-bonding, bumps up nucleophilicity, and lets synthetic schemes explore reactions at milder conditions or with different selectivities.

    Over time, we’ve tested numerous analogs in the lab. Some, like 5-bromouracil, often attract interest for mutagenesis research, but the halogen creates handling restrictions and shipping complications. 5-Aminouracil avoids those pitfalls, with a safer profile in storage and use. Its chemical reactivity unlocks transformations that would stall out with the parent compound. This difference opens more routes for pyrimidine derivatization—clients regularly point out smoother coupling reactions or fewer side-products compared to halogenated counterparts.

    From a manufacturing standpoint, another point that sets 5-Aminouracil apart lies in stability. Where other modified uracils break down in moist air or store poorly on extended timelines, our process for this product supports long shelf lives, especially when kept cool and away from direct sunlight. That’s a function of both preparation and packaging—double-layer anti-static bags, nitrogen flushing, and robust seals keep quality high during transport and storage. We’ve found that longer shelf life gives customers flexibility, especially those orchestrating multi-step syntheses or scaling up their process development work.

    Feedback from the Field: Real Engagement with Clients

    One reality that shapes our product is direct conversation with scientists and technicians. For example, several of our customers focus on DNA mismatch repair work. They’ve shared how changing from standard uracil to 5-Aminouracil alters the spectrum of mutations created in their experimental systems. The outcomes help tease apart complex biochemical pathways; a poorly controlled batch could waste weeks of work. Delivering material that behaves the same way every time avoids costly setbacks in research and trial schedules.

    On a different front, one startup working with synthetic biology platforms reported that their robotic liquid handler sometimes jammed on inconsistent product. Particle size distribution jumped out as a culprit. We worked with them to adjust our milling and sieving steps, dialing in a finer and more uniform powder that never clogged nozzles or sucked up extra solvent during dissolution. Such details rarely make it to marketing literature, yet drive real value for people at the bench.

    Manufacturing Learnings and Continuous Improvement

    Manufacturing 5-Aminouracil has taught us a lot about small molecules and the ways clients stretch their applications. Early days saw us dealing with occasional discoloration after drying, which lab analysis traced to trace oxidation from air exposure. Facility upgrades, like improved vacuum drying units and more aggressive nitrogen blanketing, nearly eliminated the problem. These lessons came from both in-house troubleshooting and open feedback—from partners sometimes reporting quirks in their applications before our QC did.

    Another challenge lived in reducing leftover solvents. Early batches sometimes carried faint odors or GC peaks at levels just above the competition. Tightening up the solvent removal stage meant tweaking not just temperature but agitation speed and vessel geometry. Our process team swapped to more efficient jacketed vessels, allowing gentler evaporation at lower pressure. Data from client labs now track reductions in background interference when they run sensitive analytics.

    In research-driven industries, trust builds over years. Customers need predictability. We log every test, every deviation, so if a batch slips out of spec, our records recall what shifted, and how. By keeping lines of communication open, we adjust quickly to changing needs, and often see clients return with custom requests—tighter water spec, different particle cut, or more intensive metal ion screening. That attention to detail means less troubleshooting for users, and a more reliable tool for their science.

    Environmental Responsibility and Safe Handling

    Manufacturing responsibility ties directly to environmental impact and operator safety. While 5-Aminouracil doesn’t rank as a particularly hazardous material, care in its handling benefits everyone down the chain. Our facility uses closed transfer systems wherever possible, limiting operator exposure. We’ve installed solvent recovery systems that reduce waste and lower emissions, and our operations log every batch’s path from precursor building blocks through final packaging.

    Disposal and handling guidelines travel with every shipment, and our technical team remains available for consultation on safe storage, compatibility, and decontamination methods. Where regulations ask for specialized packaging, or if a customer site requires extra documentation, we keep direct lines open and assist with logistics. Training and transparent sharing of best practices pay off in both reduced incidents and improved client outcomes.

    Looking Ahead: Ongoing Innovation with 5-Aminouracil

    As customer projects grow in complexity, so too does our product lineup and service. We’ve received requests for isotopically labeled 5-Aminouracil for mechanistic studies and NMR. New pathways in medicinal chemistry are demanding even closer control of chiral purity and trace contaminants. Our R&D team experiments regularly with improved purification resins and greener synthesis routes, always looking for ways to lower resource use while ramping up yield.

    Even as global regulations tighten and client requirements shift, some foundations stay the same. Listening closely to customer feedback, investing in better analytic tools, and updating plant infrastructure all feed into products that drive innovation from the bench to the clinic. In our view, manufacturing quality products starts with knowledgeable teams, open conversation, and the willingness to learn from every batch, every client interaction, and every new application in the world of 5-Aminouracil.